About Dr. Yan Fuhua
Dr. Yan Fuhua (严福华) is one of China's most distinguished radiologists and the Director of the Department of Radiology at Ruijin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine. He holds the title of Chief Physician and Professor and is nationally recognized as a leading authority on abdominal imaging, liver MRI, and oncologic radiology.
Over a career spanning more than three decades, Dr. Yan has established Ruijin Hospital's Radiology Department as one of the premier diagnostic imaging centers in China. He is particularly renowned for his expertise in liver and biliary MRI, oncologic staging and response assessment, and AI-assisted radiology — areas where his contributions have shaped national clinical guidelines and influenced radiology practice across Asia. His work on liver imaging has been instrumental in improving the accuracy of hepatocellular carcinoma diagnosis and treatment response assessment in China.
For international patients seeking expert radiological interpretation of complex imaging studies — particularly liver, pancreatic, and oncologic imaging — Dr. Yan is one of China's most sought-after radiologists for second opinion reads and multidisciplinary tumor board contributions.
Professional Positions and Affiliations
- Director, Department of Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
- Chairman, Abdominal Radiology Committee, Chinese Society of Radiology
- Vice President, Chinese Society of Radiology
- Editorial Board Member: Radiology, European Radiology, Journal of Magnetic Resonance Imaging (JMRI)
- Fellow, Radiological Society of North America (RSNA)
- Fellow, European Society of Radiology (ESR)
- Member, Asian Society of Abdominal Radiology (ASAR)
Specialties and Clinical Expertise
- Liver MRI — hepatocellular carcinoma (HCC) diagnosis and staging using LI-RADS; gadoxetate disodium (Primovist/Eovist) enhanced MRI for liver lesion characterization; treatment response assessment after TACE, ablation, and systemic therapy using mRECIST
- Pancreatic Imaging — pancreatic cancer staging and resectability assessment; IPMN characterization and surveillance; autoimmune pancreatitis diagnosis; neuroendocrine tumor imaging
- Biliary Imaging — MRCP for bile duct stones, strictures, and cholangiocarcinoma; hilar cholangiocarcinoma staging (Bismuth-Corlette classification)
- Oncologic Staging and Response Assessment — CT and MRI staging for gastrointestinal, hepatobiliary, and genitourinary cancers; RECIST and mRECIST response assessment; PET-CT interpretation coordination
- Abdominal and Pelvic MRI — rectal cancer MRI staging (mrTNM); prostate MRI (PI-RADS); adrenal lesion characterization; renal mass evaluation
- AI-Assisted Radiology — development and clinical validation of AI algorithms for liver lesion detection, HCC diagnosis, and oncologic response assessment; pioneer of AI integration into clinical radiology workflow
- Cardiac MRI — myocardial viability assessment, cardiomyopathy evaluation, and cardiac tumor characterization
- Interventional Radiology Guidance — imaging guidance and planning for TACE, ablation, and biopsy procedures in collaboration with the interventional radiology team
Academic and Research Contributions
Dr. Yan Fuhua has published over 250 peer-reviewed papers in leading international radiology journals, with a particular focus on liver MRI techniques, HCC imaging biomarkers, and the application of artificial intelligence in abdominal radiology. His landmark research on gadoxetate disodium-enhanced MRI for HCC diagnosis in Chinese patients has been widely cited and has contributed to the adoption of this technique as the preferred liver MRI protocol at major Chinese cancer centers.
He has led multicenter studies on AI-assisted HCC detection and characterization, contributing to the development of validated deep learning algorithms that are now deployed in clinical practice at multiple Chinese hospitals. His work on LI-RADS implementation in Chinese clinical practice has been instrumental in standardizing HCC imaging diagnosis across China.
Dr. Yan is Vice President of the Chinese Society of Radiology and chairs the Abdominal Radiology Committee, leading the development of national liver imaging and oncologic radiology guidelines. He is a regular invited speaker at RSNA, ECR (European Congress of Radiology), and the Asian Oceanian Congress of Radiology (AOCR).
Hospital: Ruijin Hospital Radiology Department
Under Dr. Yan's leadership, Ruijin Hospital's Radiology Department operates:
- Multiple state-of-the-art MRI Scanners including 3T systems with advanced liver and cardiac imaging protocols
- A Dual-Energy CT Program for advanced oncologic staging and liver lesion characterization
- An AI-Assisted Diagnosis Platform for liver lesion detection and HCC characterization
- A Dedicated Oncologic Imaging Team participating in all major multidisciplinary tumor boards
- A Teleradiology and Second Opinion Service for complex imaging cases from referring institutions
Why International Patients Choose Dr. Yan Fuhua
- China's leading abdominal radiologist — Vice President of the Chinese Society of Radiology and RSNA/ESR Fellow
- Liver MRI expertise — gadoxetate-enhanced MRI and LI-RADS for HCC diagnosis at the highest level
- AI radiology pioneer — developing and validating AI tools for liver cancer detection
- Oncologic staging authority — expert interpretation of complex staging imaging for treatment planning
- Second opinion reads — expert re-interpretation of overseas imaging studies for international patients
- English-language support available through CMCS concierge coordination
Practical Information for International Patients
- Hospital: Ruijin Hospital, 197 Ruijin Er Road, Huangpu District, Shanghai
- Second Opinion Service: Overseas imaging (CT, MRI, PET-CT) can be submitted for expert re-read through CMCS before travel
- Imaging at Ruijin: CMCS can arrange priority scheduling for MRI, CT, and other imaging studies at Ruijin Hospital
- Languages: Mandarin Chinese; English interpretation provided by CMCS
How CMCS Can Help
China Medical Concierge Shanghai (CMCS) provides support for international patients requiring expert radiological interpretation at Ruijin Hospital. Our services include coordination of imaging second opinion requests, priority scheduling for MRI and CT studies, translation of imaging reports (English ↔ Chinese), and integration of radiology findings into multidisciplinary consultation appointments with clinical specialists.
📧 Contact us: contract@medicalsh.com
🌐 medicalsh.com
0 comentarios